The method of Lockwood et al,' has been proposed as an appropriate screening method for excessive faecal porphyrins." During the assessment of this method, 10 faecal samples from different patients submitted to the laboratory for occult blood testing were analysed. All the samples found positive for occult blood had apparent total porphyrin concentrations greater than the upper reference limit of 200 nmol/g dry weight. Negative occult blood samples had total porphyrin concentrations less than this value.
The author replies:
Like Messrs Crothers and Lord I frequently encounter positive porphyrin screening tests when applying the method of Lockwood et al. to faecal specimens found to be positive for occult blood. In every instance analysis of the extract by HPLC has revealed increased amounts of protoporphyrin and other dicarboxylic porphyrins. This is not therefore, a shortcoming of the technique since excess amounts of porphyrins are actually present. Any good screening test will behave similarly.
It is well recognized that porphyrins are formed in the gut from haem, presumably by the action of the normal gut flora, whether the haem is of dietary origin or the result of gastrointestinal bleeding. Furthermore, porphyrins can arise directly from the diet and there has been a report of the ingestion of excessive amounts of brewers' yeast tablets resulting in a porphyrin excretion pattern mimicking variegate porphyria. I Therfore, I
would urge extreme caution in the interpretation of faecal porphyrin data and advise referral of all specimens found to give a positive screening test to a specialist laboratory with experience in the investigation of porphyria. 
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Zinc absorption in haemodialysis patients
We compliment Foote and Hinks with their work on disturbances in zinc metabolism in chronic uremia.' They stressed the role of diminished zinc absorption in the pathogenesis of zinc deficiency in chronic uremia. Subnormal plasma zinc responses were observed in haemodialysis patients during oral zinc tolerance tests. The zinc concentration in leucocytes of this group was reduced and did not improve after oral zinc supplementation. Another group of haemodialysis patients with initial low leucocyte zinc concentrations underwent dialytic zinc supplementation and showed a rise in leucocyte zinc concentration to normal levels within four months. Our group also studied zinc metabolism in haemodialysis patients. One of the symptoms in chronic uremia possibly related to a state of zinc deficiency is a diminished immunity. A group of 14 patients which in the past failed to respond with seroconversion to vaccination against hepatitis B showed a lower leucocyte zinc concentration than a group of normals (mean j Sl); 61·5±4·6 pmol/Iu" cells, vs 73·8±5·6 pmol/l O" cells, P < 0'005). The same procedure to isolate leucocytes and determine zinc concentration was used.' No difference in plasma zinc concentration between normals and patients was observed. The group of patients was divided into two age, sex and weight matched subgroups. Zinc was administered to the dialysate of one group of patients for 4 months. Seven weeks after the onset of zinc supplementation all the patients were revaccinated with a booster of 40 Ilg ofHb Vax (MS & D) injected in the deltoid muscle. AntiHBsAg titers were determined 3, 7 and 12 weeks after revaccination.
At the end of the study no difference in seroconversion rate or height of anti-HBsAg titres was observed. There was no change in plasma zinc in the non-zinc group during the trial. A steady rise in plasma zinc concentration occured in the zinc group (mean ± SD; 9·6 Ilmol/L ± I· 5 to \3·4 ± 1'9). This finding was also reported by other authors? but is not consistent with the results of Foote and Hinks who did not find an increase in plasma zinc during zinc supplementation. This difference cannot be explained by duration of dialytic supplementation or the concentration of zinc in the
